Investor profile
Neurimmune
- Portfolio companies
- 1
- Known capital represented
- $30M
Capital represented is the total size of rounds in this ledger, not the investor's individual check size.
Known activity
Portfolio rounds
Lead and participating investments
- LeadNovaGo Therapeutics
Series B · Sep 2, 2026
$30M

